POAI Predictive Oncology Inc.

Nasdaq predictive-oncology.com


$ 13.17 $ 0.00 (0 %)    

Wednesday, 15-Oct-2025 09:34:31 EDT
QQQ $ 606.53 $ 2.73 (0.45 %)
DIA $ 465.96 $ 1.32 (0.28 %)
SPY $ 669.38 $ 2.60 (0.39 %)
TLT $ 91.13 $ 0.17 (0.19 %)
GLD $ 386.56 $ 0.60 (0.16 %)
$ 13.58
$ 13.17
$ 13.25 x 175
$ 13.35 x 700
$ 13.17 - $ 13.17
$ 8.25 - $ 45.90
45,964
na
9.86M
$ 2.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-21-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-15-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 06-08-2020 03-31-2020 10-Q
23 04-01-2020 12-31-2019 10-K
24 11-15-2019 09-30-2019 10-Q
25 08-19-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 04-01-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 04-02-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-15-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-12-2016 06-30-2016 10-Q
38 05-23-2016 03-31-2016 10-Q
39 03-16-2016 12-31-2015 10-K
40 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nasdaq-jumps-150-points-us-pending-home-sales-rise

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. Following the market ...

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outst...

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their ...

 predictive-oncology-announces-1-for-15-reverse-stock-effective-september-30-2025

Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug development and discovery, today announced that it will eff...

 predictive-oncology-announces-a-strategic-collaboration-with-every-cure-to-identify-and-prioritize-drugs-for-repurposing-to-improve-patient-outcomes-and-save-lives

Predictive Oncology Inc. (NASDAQ:POAI), a leader in AI-driven drug development and discovery, and Every Cure, a leading nonprof...

 predictive-oncology-q2-eps-022-misses-009-estimate-sales-2682k-down-from-67255k-yoy

Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of...

 predictive-oncology-secures-10m-funding-to-drive-us-and-european-expansion-of-chemofx-and-fuel-ai-driven-drug-discovery

$10 million securities purchase agreement provides efficient and flexible funding in support of strategic multi-million dollar ...

 on-july-1-predictive-oncology-entered-equity-purchase-agreement-with-ya-ii-pn-ltd

-SEC Filing

Core News & Articles

Predictive Oncology Inc. (NASDAQ:POAI), a leader in AI-driven drug discovery, announced today the company has successfully deve...

Core News & Articles

Renovaro Inc. (NASDAQ:RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION